Of course in the actual report that came out in JAMA January 25, 2022, (though this report came out in the Desern Report (where you can stock up on emergency rations on the same page as the report) today, June 22, 2023, as if it were new. You do not see the 130 times more likely in the JAMA report. Nor the 1300% number. But are stuck with the study numbers reflecting VAERS reporting, which had, according to the study zero deaths reported. You are also stuck with the 1626 cases out of the 192 405 448 people, getting a total of 354 100 845 doses during the reporting period from Dec 2020 to Aug 2021. Also interesting was the fact that symptoms showed up (if they were going to show up) 3-5 days after injection, usually with the 2nd dose and that 87% were treated in hospital with non-steroid anti-inflamtory and 98% showed symptoms relieved before leaving the hospital. I was a VAERS reporter, as was my wife, neither of us having any symptoms, but being over 65, they did not choose to even consider data analyzing my group.
From the JAMA report under Discussion:
In this review of reports to VAERS between December 2020 and August 2021, myocarditis was identified as a rare but serious adverse event that can occur after mRNA-based COVID-19 vaccination, particularly in adolescent males and young men. However, this increased risk must be weighed against the benefits of COVID-19 vaccination.18
In case you would like to see the real report, although you may miss out on the emergency ration, retirment income advice, etc, here is a link:
This descriptive study compares the effect of mRNA-based COVID-19 vaccination with BNT162b2 (Pfizer-BioNTech) vs mRNA-1273 (Moderna) on the reported cases of myocarditis in the US after each vaccination dose.
jamanetwork.com